Back to search
Verified
Government
Health
Ryplle ID RYP-0649Last checked Oct 28, 2026

Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)

National Institutes of Health

Funding range
$0 – $7M
Application window
Opens: Not listed
Closes: June 20, 2029
Applications Status:Upcoming
Location
National

Source & verification

Original funding source
www.grants.gov
Last checked
October 28, 2026
Last reviewed by Ryplle
Not yet recorded

Source checks may be automated. Review dates reflect a recorded staff review. Confirm current requirements with the funder.

Eligibility at a glance

Listed applicant types
Nonprofit, Student, Business
Geographic eligibility
National
Matching funds
Not specified — check with the funder
Major exclusions
Not specified — check with the funder

Listed types are not a determination of eligibility. The funder’s full requirements take precedence.

Full eligibility requirements

Eligible applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; For profit organizations other than small businesses; City or township governments; Native American tribal governments (Federally recognized); Private institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; County governments; Native American tribal organizations (other than Federally recognized tribal governments); Independent school districts; Public and State controlled institutions of higher education; Public housing authorities/Indian housing authorities; Small businesses; Special district governments; State governments; Others (see text field entitled "Additional Information on Eligibility" for clarification).

About this grant

The purpose of this notice of funding opportunity (NOFO) is to support implementation research on strategies to improve the uptake, implementation, sustainment, scale and/or spread of evidence-based prevention, treatment, and care interventions in communities in the U.S. significantly impacted by HIV. Projects should be large in scale with high potential for research and public health impact. Specifically, large single site studies, multi-site studies, and comparative studies are encouraged as scientifically appropriate.

Contact information